MYC as a therapeutic target for the treatment of triple-negative breast cancer.

e12550Background: Despite intensive efforts, a validated targeted therapy for triple-negative breast cancer (TNBC) remains elusive. One of the most frequent genetic alterations identified in TNBC i...